Number of the records: 1  

rituximab

  1. Record numberd000069283
    Date06.06.2025
    TypeM
    Topical termrituximab
    Other termSlovak (Pseudonym) CD20 protilátka, rituximab
    Slovak (Pseudonym) IDEC-C2B8 protilátka
    Slovak (Pseudonym) GP2013
    See also(Later heading) antigény CD20
    (Skutočné meno) faktory imunologické
    (Skutočné meno) antireumatiká
    (Skutočné meno) antineoplastiká imunologické
    (Skutočné meno) antigény CD20
    UDCD12.776.124.486.485.114.224.075.785D12.776.124.790.651.114.224.075.785D12.776.377.715.548.114.224.284.785
    NoteA murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS.
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all